Community Guide
Best Peptide Stacks: What the Community Runs
Most community peptide use involves more than one compound. Stacking is the norm, not the exception — but which combinations appear repeatedly in accounts, and which combinations cause problems? This page surfaces the patterns from community confession data.
Why the community stacks peptides
Community accounts consistently describe stacking as a way to address multiple goals simultaneously or to combine compounds with complementary mechanisms. The most cited rationale: BPC-157 and TB-500 target different aspects of healing (BPC-157 for specific injury sites, TB-500 for systemic recovery and flexibility). CJC-1295 and ipamorelin are paired because they act at different points in the GH release pathway — accounts describe the combination as producing stronger and more consistent GH pulses than either alone. GLP-1 peptides are stacked with GH secretagogues in accounts targeting both fat loss and body composition simultaneously.
The BPC-157 + TB-500 stack
The most frequently appearing stack across all community accounts. BPC-157 at 250–500mcg and TB-500 at 2–2.5mg, both administered subcutaneously, run concurrently for 4–8 weeks. Community accounts describe this as the standard injury and recovery protocol — BPC-157 for targeted repair at the injury site (often injected locally), TB-500 for systemic healing and range of motion. Accounts running only one compound for recovery consistently describe less comprehensive results than those running both. The stack appears regardless of injury type: tendon, muscle, joint, gut.
The CJC-1295 + ipamorelin stack
The dominant GH secretagogue stack in community accounts, by a wide margin. CJC-1295 without DAC is the most common pairing partner — dosed at 100–200mcg alongside ipamorelin at 100–200mcg, administered before sleep. Accounts describe the combination as producing better sleep quality, improved body composition, and recovery benefits versus either peptide alone. CJC-1295 with DAC appears in accounts wanting less frequent dosing — weekly or twice-weekly injections instead of daily. The tradeoff cited: less control over timing of GH pulses.
GLP-1 stacks for body composition
Semaglutide and tirzepatide accounts increasingly describe co-administration with GH secretagogues (CJC-1295/ipamorelin or MK-677) as a body composition stack. The rationale in community accounts: GLP-1s drive the caloric deficit; GH peptides are used to preserve or build muscle during the deficit. Accounts running GLP-1s alone at significant weight loss describe muscle loss concerns — the GH secretagogue stack is the community's primary response to that concern. Retatrutide accounts note the compound's own GIP agonism reduces the need for additional stacking in some accounts.
Stacking pitfalls the community describes
The recurring warning in multi-compound accounts: introduce one peptide at a time, not all at once. Accounts that started three compounds simultaneously describe inability to attribute side effects to any specific compound. GH secretagogues stacked with GLP-1s produce occasional reports of unexpected hunger interference — ipamorelin is lower risk than older GHRP-class peptides in this regard. Melanotan II is consistently described as a solo compound in accounts, rarely stacked, due to its strong first-dose side effect profile requiring individual titration. Peptides with overlapping mechanisms — stacking two GLP-1s, for example — appear in accounts as overdose scenarios, not intentional protocols.
Related peptides:
Browse topics:
Community Q&A
- What is the most popular peptide stack?
- By frequency in community accounts: BPC-157 + TB-500 for recovery and healing, and CJC-1295 + ipamorelin for GH support and body composition. Both appear across a wide range of user profiles and goals. The GLP-1 + GH secretagogue combination (semaglutide or tirzepatide with CJC-1295/ipamorelin) is increasingly common in accounts targeting fat loss with muscle preservation.
- Can you stack BPC-157 and TB-500?
- Yes — this is the most documented combination in community accounts. BPC-157 at 250–500mcg and TB-500 at 2–2.5mg are run concurrently, typically for 4–8 weeks. Community accounts describe complementary mechanisms: BPC-157 for site-specific repair, TB-500 for systemic healing and flexibility. Side effect rates for this combination are among the lowest of any stack in the data.
- Should you stack CJC-1295 with ipamorelin?
- Community accounts consistently describe the combination as more effective than either peptide alone for GH support. CJC-1295 (GHRH analogue) and ipamorelin (GHRP) act at different points in the GH release pathway — accounts describe a synergistic effect on GH pulse amplitude. The standard protocol in accounts: 100–200mcg of each, dosed together before sleep.
- Can you stack peptides with semaglutide or tirzepatide?
- Community accounts describe stacking GH secretagogues (CJC-1295 + ipamorelin, or MK-677) with GLP-1s specifically to offset muscle loss during aggressive caloric restriction. The combination is described as targeting both fat loss and body composition simultaneously. Accounts warn against stacking two GLP-1 class compounds — reports describe this as producing severe nausea and over-restriction rather than additive benefit.
- How long should you run a peptide stack?
- Community accounts cluster around 8–12 weeks for GH secretagogue stacks, 4–8 weeks for healing stacks, and ongoing (with periodic breaks) for GLP-1 protocols. The recurring pattern: 8–12 weeks on, 4–8 weeks off for GH peptides to maintain pituitary sensitivity. Healing stacks are run until the target injury resolves, then discontinued. GLP-1 accounts describe maintenance dosing indefinitely at reduced frequency rather than full discontinuation.